Dialysis-related infections are the commonest cause of catheter loss and transfer to hemodialysis. Surface modifications of the catheter that reduce infections are of major importance.
♦ Objective
The efficacy of silver-ion treated catheters in reducing dialysis-related infections was tested.
♦ Methods
The study design was a prospective, randomized controlled trial. Patients were implanted with either a silver-treated study catheter or a control catheter. Prospective collection of data included infectious complications and catheter survival.
♦ Results
The subject groups were comprised of 67 silver-treated catheters and 72 control catheters. Demographic characteristics of the study and control groups were equal. Exit-site infection rates for the study group and control group (0.52 and 0.45 episodes/patient-year of dialysis respectively) were not different by Poisson regression analysis (p > 0.4). Peritonitis rates were identical for the two groups (0.37 episodes/patient-year) and were not different by Poisson analysis (p > 0.9). Antibiotic-free intervals between infections for the study and control groups were not significantly different for exit-site infections (p = 0.58), peritonitis (p = 0.44), or both infections combined (p = 0.47). Actuarial analyses showed no differences between the groups in the probability of remaining free of exit-site infection (p> 0.2) or peritonitis (p > 0.7). Similarly, catheter survival was not significantly different between the groups (p > 0.6).
♦ Conclusion
Surface modification of catheters with ion beam implantation of silver produced no clinical effect with respect to reducing dialysis-related infections.
BoswaldM, GirischM, GreilJ, SpiesT, StehrK, KrallT. Antimicrobial activity and biocompatibility of polyurethane and silicone catheters containing low concentrations of silver: a new perspective in prevention of polymer-associated foreign-body infections. Zentralbl Bakteriol1995; 283:187–200.
4.
DavenasJ, ThevenardP, PhilippeF, ArnaudMN. Surface implantation treatments to prevent infection complications in short term devices. Biomol Eng2002; 19: 263–8.
5.
CrabtreeJH, FishmanA. A laparoscopic approach under local anesthesia for peritoneal dialysis access. Perit Dial Int2000; 20:757–65.
6.
CrabtreeJH, HadnottLL, BurchetteRJ, SiddiqiRA. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Adv Perit Dial2000; 16:271–5.
DasguptaMK, BettcherKB, UlanRA, BurnsV, LamK, DossetorJB. Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull1987; 7:168–73.
10.
KathuriaP, MooreHL, ProwantBF, KhannaR, TwardowskiZJ. Preliminary evaluation of silver-coated peritoneal catheters in rats. Adv Perit Dial1995; 11: 189–92.
11.
KathuriaP, MooreHL, MehrotraR, ProwantBF, KhannaR, TwardowskiZJ. Evaluation of healing and external tunnel histology of silver-coated peritoneal catheters in rats. Adv Perit Dial1996; 12:203–8.
12.
FungLCT, KhouryAE, VasSI, SmithC, OreopoulosDG, MittelmanMW. Biocompatibility of silver-coated peritoneal dialysis catheter in a porcine model. Perit Dial Int1996; 16:398–405.
13.
BambauerR, MestresP, SchielR, SchneidewindJM, LatzaR, BambauerS. Surface treated catheters with ion beam based process for blood access. Ther Apher2000; 4:342–7.
14.
AshSR. Sterling silver as an antibacterial peritoneal catheter material: the mini-Lifecath [Abstract]. Perit Dial Int1988; 8:64.
15.
PommerW, BraunerM, WestphaleHJ, BrunkhorstR, KramerR, BundschuD. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study. Am J Kidney Dis1998; 32:752–60.
16.
GuggenbichlerJP, BoswaldM, LugauerS, KrallT. A new technology of microdispersed silver in polyure-thane induces antimicrobial activity in central venous catheters. Infection1999; 27(Suppl 1):S16–23.
17.
BoswaldM, LugauerS, RegenfusA, BraunGG, MartusP, GeisC. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection1999; 27(Suppl 1):S56–60.
18.
StoiserB, KoflerJ, StaudingerT, GeorgopoulosA, LagauerS, GuggenbichlerJP. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Infect2002; 50:202–6.
19.
SzycherM. Biostability of polyurethane elastomers: a critical review. J Biomater Appl1988; 3:297–402.
20.
CrabtreeJH. Clinical biodurability of aliphatic polyether-based polyurethanes as peritoneal dialysis catheters. ASAIO J2003; 49:290–4.
